Market Research Report

Global Companion Animal Vaccines Market Report By Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), By Species Type (Canine, Avian, Feline, Equine), By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Retail Pharmacies, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11217927
April 2022
Report Formats: Report Formats
The global demand for Companion Animal Vaccines Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Companion animal vaccines are essential for sustaining the longevity, good health, and overall productivity of pets while remaining cost-effective. Vaccines for companion animals minimise illness transfer from animals to people. Companion animal vaccinations are parenteral medications used in the prevention of diseases like blastomycosis, psittacosis, cat scratch disease, and others. Vaccines for companion animals are used to activate and improve an animal's immune system against a number of diseases. Companion animal immunizations guarantee that pets stay healthy and live a long time. Companion animal vaccines are beneficial in lowering the need for and cost of other medicinal treatments. 

Market Dynamics 

The increase in scientific advances in the biotechnology industry is one of the key reasons accelerating the market for companion animal vaccines. Another predictor of market growth for companion animal vaccinations is the increasing number of animal welfare campaigns. Growing government activities to raise awareness, an increase in the number of companion animals, and rising personal disposable money will all contribute to profitable companion animal vaccines market growth potential. High storage costs, on the other hand, will operate as a market growth barrier for companion animal vaccines.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of companion animal vaccines. The growth and trends of companion animal vaccines industry provide a holistic approach to this study. 

Market Segmentation

This section of the companion animal vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Dna Vaccines
  • Recombinant Vaccines

By Species Type
  • Canine
  • Avian
  • Feline
  • Equine

By Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Companion Animal Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Companion Animal Vaccines Market Share by Region (Representative Graph)

Global Companion Animal Vaccines Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the companion animal vaccines market include Pfizer, Bioniche Animal Health (Canada), Merck Animal Health (U.S), Novartis Animal Health Inc., Sanofi-Aventis, Bayer Healthcare, Zoetis (U.S), Heska Corporation, Virbac, Ceva Animal Health, Inc., Merial Inc. (Sanofi), Boehringer Ingelheim (Germany), Elanco. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Frequently Asked Questions (FAQs) about this Report

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . COMPANION ANIMAL VACCINES – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Product Type
           3.7.2 Market Attractiveness Analysis By Species Type
           3.7.3 Market Attractiveness Analysis By Distribution Channel
           3.7.4 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL COMPANION ANIMAL VACCINES MARKET ANALYSIS BY PRODUCT TYPE
       6.1 Overview by Product Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Product Type
       6.4 Attenuated Live Vaccines Historic and Forecast Sales by Regions
       6.5 Conjugate Vaccines Historic and Forecast Sales by Regions
       6.6 Inactivated Vaccines Historic and Forecast Sales by Regions
       6.7 Subunit Vaccines Historic and Forecast Sales by Regions
       6.8 Toxoid Vaccines Historic and Forecast Sales by Regions
       6.9 DNA Vaccines Historic and Forecast Sales by Regions
       6.10. Recombinant Vaccines Historic and Forecast Sales by Regions
 
7 . GLOBAL COMPANION ANIMAL VACCINES MARKET ANALYSIS BY SPECIES TYPE
       7.1 Overview by Species Type
       7.2 Historical and Forecast Data
       7.3 Analysis by Species Type
       7.4 Canine Historic and Forecast Sales by Regions
       7.5 Avian Historic and Forecast Sales by Regions
       7.6 Feline Historic and Forecast Sales by Regions
       7.7 Equine Historic and Forecast Sales by Regions
 
8 . GLOBAL COMPANION ANIMAL VACCINES MARKET SALES ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical and Forecast Data
       8.3 Analysis by Distribution Channel
       8.4 Veterinary Clinics Historic and Forecast Sales by Regions
       8.5 Veterinary Hospitals Historic and Forecast Sales by Regions
       8.6 Veterinary Research Institutes Historic and Forecast Sales by Regions
       8.7 Retail Pharmacies Historic and Forecast Sales by Regions
       8.8 Others Historic and Forecast Sales by Regions
 
9 . GLOBAL COMPANION ANIMAL VACCINES MARKET SALES ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook Sales Analysis
       9.2. Introduction Sales Analysis
       9.3. North America Sales Analysis
           9.3.1. Overview, Historic and Forecast Sales Analysis
           9.3.2. North America By Segment Sales Analysis
           9.3.3. North America By Country Sales Analysis
           9.3.4. United State Sales Analysis
           9.3.5. Canada Sales Analysis
           9.3.6. Mexico Sales Analysis
       9.4. Europe Sales Analysis
           9.4.1. Overview, Historic and Forecast Sales Analysis
           9.4.2. Europe by Segment Sales Analysis
           9.4.3. Europe by Country Sales Analysis
           9.4.4. United Kingdom Sales Analysis
           9.4.5. France Sales Analysis
           9.4.6. Germany Sales Analysis
           9.4.7. Italy Sales Analysis
           9.4.8. Russia Sales Analysis
           9.4.9. Rest Of Europe Sales Analysis
       9.5. Asia Pacific Sales Analysis
           9.5.1. Overview, Historic and Forecast Sales Analysis
           9.5.2. Asia Pacific by Segment Sales Analysis
           9.5.3. Asia Pacific by Country Sales Analysis
           9.5.4. China Sales Analysis
           9.5.5. India Sales Analysis
           9.5.6. Japan Sales Analysis
           9.5.7. South Korea Sales Analysis
           9.5.8. Australia Sales Analysis
           9.5.9. Rest Of Asia Pacific Sales Analysis
       9.6. Latin America Sales Analysis
           9.6.1. Overview, Historic and Forecast Sales Analysis
           9.6.2. Latin America by Segment Sales Analysis
           9.6.3. Latin America by Country Sales Analysis
           9.6.4. Brazil Sales Analysis
           9.6.5. Argentina Sales Analysis
           9.6.6. Peru Sales Analysis
           9.6.7. Chile Sales Analysis
           9.6.8. Rest of Latin America Sales Analysis
       9.7. Middle East & Africa Sales Analysis
           9.7.1. Overview, Historic and Forecast Sales Analysis
           9.7.2. Middle East & Africa by Segment Sales Analysis
           9.7.3. Middle East & Africa by Country Sales Analysis
           9.7.4. Saudi Arabia Sales Analysis
           9.7.5. UAE Sales Analysis
           9.7.6. Israel Sales Analysis
           9.7.7. South Africa Sales Analysis
           9.7.8. Rest Of Middle East And Africa Sales Analysis
 
10 . COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL VACCINES COMPANIES
       10.1. Companion Animal Vaccines Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF COMPANION ANIMAL VACCINES INDUSTRY
       11.1. Top 10  Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Pfizer
           11.3.1. Company Overview
           11.3.2. Company Revenue
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Bioniche Animal Health (Canada)
           11.4.1. Company Overview
           11.4.2. Company Revenue
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Merck Animal Health (U.S)
           11.5.1. Company Overview
           11.5.2. Company Revenue
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Novartis Animal Health Inc.
           11.6.1. Company Overview
           11.6.2. Company Revenue
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Sanofi-Aventis
           11.7.1. Company Overview
           11.7.2. Company Revenue
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Bayer Healthcare
           11.8.1. Company Overview
           11.8.2. Company Revenue
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Zoetis (U.S)
           11.9.1. Company Overview
           11.9.2. Company Revenue
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Heska Corporation
           11.10.1. Company Overview
           11.10.2. Company Revenue
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Virbac
           11.11.1. Company Overview
           11.11.2. Company Revenue
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Ceva Animal Health Inc.
           11.12.1. Company Overview
           11.12.2. Company Revenue
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Merial Inc. (Sanofi)
           11.13.1. Company Overview
           11.13.2. Company Revenue
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. Boehringer Ingelheim (Germany)
           11.14.1. Company Overview
           11.14.2. Company Revenue
           11.14.3. Products
           11.14.4. Recent Developments
       11.15. Elanco
           11.15.1. Company Overview
           11.15.2. Company Revenue
           11.15.3. Products
           11.15.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product Type (USD MN)
  •  Attenuated Live Vaccines Market Sales by Geography (USD MN)
  •  Conjugate Vaccines Market Sales by Geography (USD MN)
  •  Inactivated Vaccines Market Sales by Geography (USD MN)
  •  Subunit Vaccines Market Sales by Geography (USD MN)
  •  Toxoid Vaccines Market Sales by Geography (USD MN)
  •  DNA Vaccines Market Sales by Geography (USD MN)
  •  Recombinant Vaccines Market Sales by Geography (USD MN)
  •  Analysis Market by Species Type (USD MN)
  •  Canine Market Sales by Geography (USD MN)
  •  Avian Market Sales by Geography (USD MN)
  •  Feline Market Sales by Geography (USD MN)
  •  Equine Market Sales by Geography (USD MN)
  •  Analysis by Distribution Channel (USD MN)
  •  Veterinary Clinics Market Sales by Geography (USD MN)
  •  Veterinary Hospitals Market Sales by Geography (USD MN)
  •  Veterinary Research Institutes Market Sales by Geography (USD MN)
  •  Retail Pharmacies Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Companion Animal Vaccines Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Companion Animal Vaccines Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Companion Animal Vaccines Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product Type
  •  Market Attractiveness Analysis by Species Type
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product Type (USD MN)
  •  Attenuated Live Vaccines Market Sales by Geography (USD MN)
  •  Conjugate Vaccines Market Sales by Geography (USD MN)
  •  Inactivated Vaccines Market Sales by Geography (USD MN)
  •  Subunit Vaccines Market Sales by Geography (USD MN)
  •  Toxoid Vaccines Market Sales by Geography (USD MN)
  •  DNA Vaccines Market Sales by Geography (USD MN)
  •  Recombinant Vaccines Market Sales by Geography (USD MN)
  •  Global Market Analysis by Species Type (USD MN)
  •  Canine Market Sales by Geography (USD MN)
  •  Avian Market Sales by Geography (USD MN)
  •  Feline Market Sales by Geography (USD MN)
  •  Equine Market Sales by Geography (USD MN)
  •  Global Market Analysis by Distribution Channel (USD MN)
  •  Veterinary Clinics Market Sales by Geography (USD MN)
  •  Veterinary Hospitals Market Sales by Geography (USD MN)
  •  Veterinary Research Institutes Market Sales by Geography (USD MN)
  •  Retail Pharmacies Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials